CMV retinitis and the use of FK 506.
Paul
A A
AA
Eye and Ear Institute, University of Pittsburgh, Pennsylvania.
Leeper
H F
HF
Friberg
T R
TR
D000212:Acyclovir / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D003586:Cytomegalovirus Infections / Q000188:drug therapy / Q000209:etiology*; D017245:Foscarnet; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D010746:Phosphonoacetic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D012173:Retinitis / Q000188:drug therapy / Q000382:microbiology*; D012189:Retrospective Studies; D016559:Tacrolimus / Q000627:therapeutic use*; D014181:Transplantation Immunology
D000998:Antiviral Agents; D017245:Foscarnet; D010746:Phosphonoacetic Acid; D016559:Tacrolimus; D000212:Acyclovir